Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat

Overview of attention for article published in BMC Research Notes, May 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 46 Dimensions

Readers on

mendeley: 25 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

PHARMACEUTICAL COMPOSITION FOR SUPPRESSING ORGAN FIBROSIS

Application WO-2023140350-A1

World Intellectual Property Organisation (WIPO)

Medicine obtained by combining FXR agonist and ARB

Grant US-11419878-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.